MARINUS

Serial Number 97139236
Registration 7237360
700

Registration Progress

Application Filed
Nov 23, 2021
Under Examination
Dec 13, 2022
Approved for Publication
Oct 18, 2022
Published for Opposition
Oct 18, 2022
Registered
Dec 5, 2023

Trademark Image

MARINUS

Basic Information

Serial Number
97139236
Registration Number
7237360
Filing Date
November 23, 2021
Registration Date
December 5, 2023
Published for Opposition
October 18, 2022
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 5, 2023
Registration
Registered
Classes
005

Rights Holder

Marinus Pharmaceuticals, Inc.

03
Address
5 Radnor Corporate Center, Suite 500
100 Matsonford Road
Radnor, PA 19087

Ownership History

Marinus Pharmaceuticals, Inc.

Original Applicant
03
Radnor, PA

Marinus Pharmaceuticals, Inc.

Owner at Publication
03
Radnor, PA

Marinus Pharmaceuticals, Inc.

Original Registrant
03
Radnor, PA

Legal Representation

Attorney
Keith Barritt

USPTO Deadlines

Next Deadline
1420 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20231205)
Due Date
December 05, 2029
Grace Period Ends
June 05, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Dec 5, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 5, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 3, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 2, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 16, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 28, 2023 IUAF S USE AMENDMENT FILED Loading...
Oct 10, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 28, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jan 25, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 23, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 23, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 23, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 13, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 18, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 18, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 28, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 9, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 9, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 9, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 9, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Sep 9, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 4, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 30, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 29, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 26, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of seizures and epilepsy, status epilepticus, epileptic encephalopathies, encephalopathies, seizures, genetic seizure disorders, movement disorders, neurologic conditions, neurodegenerative disease, cerebrovascular disease, traumatic brain injury, substance abuse, substance withdrawal, dementia, delirium, schizophrenia, bipolar disorder, psychosis, psychiatric conditions, and depression
First Use Anywhere: Sep 15, 2023
First Use in Commerce: Sep 15, 2023

Additional Information

Design Mark
The mark consists of three non-concentric overlapping circles of different sizes to the left of the stylized word "MARINUS".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005